Anixa Biosciences Inc (ANIX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $3.04
• Market Cap: $100.81M
• EPS: $-0.34
• 52-Week High: $5.46
• 52-Week Low: $2.33

Market Sentiment

Anixa Biosciences Inc currently has a Bullish sentiment score of 0.34.

About Anixa Biosciences Inc

Anixa Biosciences Inc. is a forefront biotechnology company located in San Jose, California, dedicated to addressing critical unmet medical needs in oncology and infectious diseases through the development of groundbreaking therapies and vaccines. The firm is characterized by a robust pipeline fueled by cutting-edge technologies aimed at improving patient outcomes in challenging health scenarios. By strategically focusing on high-impact sectors within the biopharmaceutical landscape, Anixa is...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Anixa Biosciences Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ANIX pay dividends?

Anixa Biosciences Inc (ANIX) does not currently pay a regular dividend.

What is ANIX's market cap?

Anixa Biosciences Inc (ANIX) has a market capitalization of $100.81M with a current stock price of $3.04.